Research programme - COVID-2019 infection vaccine - Cristal Therapeutics/Intravacc
Alternative Names: COVID-2019 infection vaccine - Intravacc/Cristal TherapeuticsLatest Information Update: 14 Jan 2021
At a glance
- Originator Cristal Therapeutics; Intravacc
- Class COVID-19 vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research COVID 2019 infections